类有机物
肝细胞癌
转录组
癌症研究
医学
药品
药物治疗
癌症治疗
生物
药物发现
药物开发
癌症
癌
肝癌
药物代谢
作者
Dan He,Zhong Liang,Chengyang Zhang,Jun Xian,Yuanxiang Yang,Yuan-Feng Gong,Hui Tang,Zhou Guang-ding,Chen-Yu Jiang,Le Xing,Dong-Mei Li,Ying‐Chen Claire Hou,Yue Chen,Wei Cheng,Yun-Qiang Tang,Ming Liu,Xiao-Feng Zhang
摘要
Hepatocellular carcinoma is a major cause of cancer-related mortality worldwide and is characterized by marked intratumoral heterogeneity, which contributes to variable treatment responses, tumor recurrence, and disease progression. A deeper understanding of how tumor cells change at the transcriptional level before and after drug treatment is therefore essential for improving therapeutic strategies. However, practical experimental workflows that connect organoid-based drug treatment with downstream single-cell transcriptomic profiling remain limited. In this study, a standardized workflow for generating hepatocellular carcinoma organoids, applying defined drug treatment, and performing single-cell RNA sequencing on samples collected before and after treatment is developed. The protocol includes organoid revival and expansion, pre-treatment quality assessment, drug exposure, organoid preparation for single-cell dissociation, library construction, and basic comparative analysis of single-cell transcriptomic data. Critical technical precautions are provided to improve reproducibility and sample quality. This workflow enables side-by-side characterization of cellular composition and transcriptional changes associated with drug treatment in hepatocellular carcinoma organoids. The protocol is robust, scalable, and adaptable across different organoid systems, providing a practical platform for investigating treatment-associated gene expression changes at single-cell resolution.
科研通智能强力驱动
Strongly Powered by AbleSci AI